InsidersTradesSigma
申报总数
公司
▲ 买入（5 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
5
已披露卖出
0
T+90 胜率
100%
T+90 平均收益
+20.4%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Explore the full record of transactions filed by Kaplan Myron, 董事. Director active across 1 company, notably CorMedix Inc.. Cumulatively, 8 filings have been published. Breakdown: 5 buys · 0 sell. Total volume traded: €400k. Activity tracked since 17 May 2021. The latest transaction was filed on 26 January 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Kaplan Myron
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报8 总计
30,453 股0Common StockSEC:0001213900-26-008473:0
25,000 股@ US$11.0259.3% 占其流量Common StockSEC:0001213900-25-102764:0
标准退出：2026年1月21日 (T+90)
25,000 股0Common StockSEC:0001213900-25-005671:0
6,000 股@ US$4.5439.0% 占其流量Common StockSEC:0000929638-23-001538:0
标准退出：2023年8月16日 (T+90)
5,000 股@ US$3.780.0019% mcap7.0% 占其流量Common StockSEC:0001213900-22-027983:0
标准退出：2022年8月15日 (T+90)
20,000 股0Common StockSEC:0001213900-21-067924:0
10,000 股@ US$5.1411.3% 占其流量Common StockSEC:0001213900-21-060879:0
标准退出：2022年2月14日 (T+90)
15,000 股@ US$6.031818.6% 占其流量Common StockSEC:0001213900-21-027991:0
标准退出：2021年8月15日 (T+90)
8 条申报中的 8 条
About Kaplan Myron
Myron Kaplan is a Board Member at CorMedix Inc. He brings valuable expertise in corporate governance and strategy. His role involves overseeing the company's operations and ensuring that shareholder interests are protected. Kaplan plays a key role in strategic decision-making and guiding the company towards its long-term goals.
